Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Niflumic acid

Alternative Names: niflumic acid
Clinical Status: Inactive
Latest Update: 2024-09-07
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Algeria | Belgium | Chile | Dominican Republic | Egypt | France | Greece | Hungary | India | Ireland | Italy | Luxembourg | Morocco | Pakistan | Peru | Portugal | Spain | Taiwan | Tunisia

Approved Indications: None

Known Adverse Events: None

Company: University Hospital Of Clermont-Ferrand
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 4: Osteoarthritis, Hip|Osteoarthritis, Knee

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated
RBHP 2022 DUALE

P4

Recruiting

Osteoarthritis, Hip|Osteoarthritis, Knee

2025-03-01

2025-05-02

Treatments

Recent News Events

Date

Type

Title

01/06/2024

PubMed

 Mechanism of anion exchange and small-molecule inhibition of pendrin.

12/01/2023

PubMed

 Roles of endothelial prostaglandin I2 in maintaining synchronous spontaneous Ca2+ transients in rectal capillary pericytes.

10/15/2023

PubMed

 Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions